Racial, ethnic, and socioeconomic survival disparities among children with high-risk neuroblastoma treated on upfront Children's Oncology Group clinical trials.

被引：0

作者：

Umaretiya, Puja J.

Naranjo, Arlene

Zhang, Fan

Park, Julie R.

Weiss, Brian D.

Granger, Meaghan

DuBois, Steven G.

Bagatell, Rochelle

Bona, Kira

机构：

[1] Dana Farber & Boston Childrens Canc & Blood Disor, Boston, MA USA

[2] Univ Florida, Childrens Oncol Grp, Stat & Data Ctr, Gainesville, FL USA

[3] Canc & Blood Disorders Ctr, Seattle, WA USA

[4] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA

[5] Cook Childrens Med Ctr, Ft Worth, TX USA

[6] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA

[7] Childrens Hosp Philadelphia, Philadelphia, PA USA

[8] Childrens Hosp Boston, Dana Farber Canc Inst, Boston, MA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

10005

引用

页数：1

共 50 条

[31] Access to Children's Oncology Group and Pediatric Brain Tumor Consortium Phase 1 Clinical Trials: Racial/Ethnic Dissimilarities in Participation
Nooka, Ajay K.
Behera, Madhusmita
Lonial, Sagar
Dixon, Margie D.
Ramalingam, Suresh S.
Pentz, Rebecca D.
CANCER, 2016, 122 (20) : 3207 - 3214
[32] Efficacy of complete resection for high-risk neuroblastoma: A children's cancer group study
Adkins, ES
Sawin, R
Gerbing, RB
London, WB
Matthay, KK
Haase, GM
JOURNAL OF PEDIATRIC SURGERY, 2004, 39 (06) : 931 - 936
[33] Assessment of enrollment characteristics for Children's Oncology Group (COG) upfront therapeutic clinical trials 2004-2015
Faulk, Kelly E.
Anderson-Mellies, Amy
Cockburn, Myles
Green, Adam L.
PLOS ONE, 2020, 15 (04):
[34] Assessment of enrollment characteristics for Children's Oncology Group (COG) upfront therapeutic clinical trials 2004-2015.
Faulk, Kelly
Anderson-Mellies, Amy
Cockburn, Myles
Green, Adam
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[35] Changes in T-cell repertoire during high-risk neuroblastoma therapy: A report from the Children's Oncology Group
Jiang, Yiyue
Nabbi, Arash
Danesh, Arnavaz
Pedersen, Stephanie
Eagles, Jenna
Naranjo, Arlene
Tan, Kai
Collins, Natalie
DuBois, Steven G.
Bagatell, Rochelle
Crompton, Brian D.
Pugh, Trevor J.
CANCER RESEARCH, 2024, 84 (17)
[36] Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the US and Canada: A Pooled Analysis of Children's Oncology Group Trials
Kahn, Justine M.
Kelly, Kara M.
Pei, Qinglin
Friedman, Debra L.
Keller, Frank
Bush, Rizvan
Bhatia, Smita
Henderson, Tara O.
Schwartz, Cindy L.
Castellino, Sharon M.
BLOOD, 2017, 130
[37] Area-Based Socioeconomic Disparities in Survival of Children with Newly Diagnosed Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Winestone, Lena E.
Getz, Kelly D.
Bona, Kira O.
Fisher, Brian T.
Gamis, Alan S.
Seif, Alix E.
Sung, Lillian
Wang, Yi-Cheng
Alonzo, Todd A.
Aplenc, Richard
BLOOD, 2019, 134
[38] Attention and executive functioning in children and adolescents treated for high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG)
Hardy, Kristina K.
Embry, Leanne
Kairalla, John A.
Sharkey, Christina
Gioia, Anthony R.
Griffin, Danielle
Berger, Carly
Weisman, Hannah S.
Noll, Robert B.
Winick, Naomi J.
PEDIATRIC BLOOD & CANCER, 2024, 71 (11)
[39] Attention and Executive Functioning in Children and Adolescents Treated for High-Risk Acute Lymphoblastic Leukaemia: A Report From the Children's Oncology Group (COG)
Cohen, Ian J.
PEDIATRIC BLOOD & CANCER, 2025,
[40] RETROSPECTIVE EVALUATION OF CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA TREATED AT THE CHILDREN'S CANCER INSTITUTE IN LEBANON
Saad, F.
Nader, R.
Akel, S.
Abboud, M.
Muwakkit, S.
El Solh, H.
Saab, R.
PEDIATRIC BLOOD & CANCER, 2014, 61 : S334 - S334

← 1 2 3 4 5 →